A Review of Liquid Biopsy Regulatory Considerations, Current Utility & Future Direction

Time: 7:40 pm
day: Labcorp Engager


  • Liquid biopsy regulatory considerations, including FDA guidance, clinical study design and evidence reporting
  • Benefits of modeling bridging studies and PMA submission strategy well ahead of time
  • How to efficiently leverage this complementary approach to enable better access to potential treatment options for patients